Research Article | Open Access
Volume 2021 - 2 | Article ID 193 | http://dx.doi.org/10.51521/JPEM.2021.22111
Academic Editor: Mari Uyeda
NIKHIL ARUN SHETE*, DR. ANIL
PAWAR, VAIJAYANTI LOKHANDE, VISHWAJEET SWAMI, DR. V. K. DESHMUKH
1Mula Education Societys
College of Pharmacy, Sonai, Ahemadnagar, Newasa, Maharashtra-414105.
2Mula Education Societys
College of Pharmacy, Sonai, Ahemadnagar, Newasa, Maharashtra-414105.
3Mula Rural Institute
College of Pharmacy Sonai, Ahemadnagar, Newasa, Maharashtra-414105.
4Dr. D.Y. Patil institute
of Pharmaceutical Sciences and Research Pimpri Pune - 18.
5Mula Education Societys
College of Pharmacy, Sonai, Ahemadnagar, Newasa, Maharashtra-414105.
Corresponding
Author: Nikhil Arun Shete, Mula Education Societys
College of Pharmacy, Sonai, Ahemadnagar, Newasa, Maharashtra-414105. Email Id:
nikhilshete300@gmail.com
Citation:
Nikhil Arun Shete, Dr. Anil Pawar, Vaijayanti Lokhande, Vishwajeet Swami, Dr.
V.K. Deshmukh (2021) QBD Based Development and Validation of a Stability
Indicating UHPLC Method for Pioglitazone And Glimepiride. J Pharm Exper Med,
2(2);1-8.
Copy
Rights: © 2021, Nikhil Arun Shete. This is an open-access
article distributed under the terms of the Creative Commons Attribution 4.0
International License, which permits unrestricted use, distribution and
reproduction in any medium, provided the original author and source are
credited.
ABSTRACT:
Quality by Design (QbD) refers to the
achievement of certain predictable quality with desired and predetermined
specifications. In an attempt to reduce rising development costs and regulatory
barriers to innovation and creativity. In the pharmaceutical world, is
considered as any other organic material, besides the drug substance, or
ingredients arise out of synthesis or an unwanted chemical that remains with
API’s. The present study describes a simple, accurate, precise and cost
effective Reverse Phase High Performance Liquid Chromatographic (RP-HPLC)
method for determination pioglitazone and Glimepiride from bulk and
formulation. RP-HPLC method was developed to identify and quantify the
pioglitazone and Glimepiride in bulk and formulation as per ICH Q2 (R1)
guidelines. Optimization was done by response surface methodology, applying a
three level full factorial design. Two factors selected were methanol
concentration in mobile phase, and flow rate. The separation was carried out
using gilent 4.5 X 100mm 2.5um column. Detection was done using UV detector at
225nm. The developed method employed mobile phase methanol: (0.1%) water
(75:25) (pH 3.2) temperature 27℃ and flow rate
0.7 ml/min, which was optimized with the help of design expert software. High
linearity of the developed method was confirmed over concentration range of
15-75&2-10 μg/mL
for pioglitazone and Glimepiride with correlation coefficient of 0.998 and
0.999. The percentage RSD for precision and accuracy of the method was found to
be less than 2%. Peaks were obtained at retention times of 2.9333 & 6.9667
min respectively for pioglitazone and Glimepiride The proposed method can be
successfully used to determine the drug contents of marketed formulation.
KEYWORDS:
Quality By Design, Reverse Phase High
Performance Liquid Chromatographic, Pioglitazone, Glimepiride, Optimization,
Mobile Phase.